592
Views
2
CrossRef citations to date
0
Altmetric
Articles

Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents

ORCID Icon, , , , &
Pages 1435-1448 | Received 13 Aug 2020, Accepted 16 Sep 2020, Published online: 20 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mónica Munera-Campos, Jaime Vilar-Alejo, Raquel Rivera, Jose-Manuel Carrascosa, Esteban Daudén, Enrique Herrera-Acosta, Antonio Sahuquillo-Torralba, Francisco J. Gómez-García, Ofelia Baniandrés-Rodríguez, Pablo de la Cueva, Jose-Luis López-Estebaranz, Isabel Belinchón, Marta Ferran, Jose Riera-Monroig, Lourdes Rodriguez, Gregorio Carretero, Carmen García-Donoso, Ferran Ballescá, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Conrad Pujol-Marco, Lula María Nieto-Benito, Diana P. Ruiz-Genao, Mercè Alsina, Miguel A. Descalzo & Ignacio García-Doval. (2022) The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. Journal of Dermatological Treatment 33:4, pages 2110-2117.
Read now

Articles from other publishers (1)

L. Penso, R. Dray‐Spira, A. Weill, M. Zureik & E. Sbidian. (2021) Psoriasis‐related treatment exposure and hospitalization or in‐hospital mortality due to COVID‐19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France*. British Journal of Dermatology 186:1, pages 59-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.